✦ LIBER ✦

Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: A French payer perspective

✍ Scribed by Chevalier, Julie; Delaitre, Olivier; Hammès, Florence; de Pouvourville, Gérard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of dabigatran etexila

✍ Sorensen, S. V.; Kansal, A. R.; Connolly, S.; Peng, S.; Linnehan, J.; Bradley-Ke 📂 Article 📅 2011 🏛 Schattauer 🌐 English ⚖ 309 KB

PCV59 Cost-Effectiveness of Dabigatran E

✍ Y.B. Belousov; V.Y. Mareev; D.Y. Belousov; E.V. Afanasieva; Y.I. Ashikhmin; A.V. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost-Effectiveness Analysis of Apixaban

✍ Betegón Nicolás, L.; Escolar Albaladejo, G.; Canal Fontcuberta, C.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Self-management of Vitamin K Antagonists

✍ Souto, Juan C.; Ruyra, Xavier; Bayes-Genis, Antoni 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Self-management of Vitamin K Antagonists

✍ González-Juanatey, José R.; Lobos, José M.; Reverter, Joan C.; Becerra, Virginia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 81 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB